Slide 1

What's the Best Brew for Grandma? 2012 Beers List Update Hospitalist Best Practice J Rush Pierce Jr, MD, MPH June 20, 2012 Slide 2 Disclosures I am member and serve on Emergency Preparedness Special Interest Group for the American Geriatrics Society, who played a major role in the 2012 Beers update 5% of my salary supported by Donald W Reynolds Foundation for education of hospital care of the elderly Slide 3 Agenda Background of Beers list (rationale, history, methodology of update) Focused review of update Usefulness and limitations Relevance to hospital medicine/resources Slide 4 What the Beers list is not Slide 5 Beers list - background 1991 for use in NHs 1997 update for elderly in all settings 1999 adopted by CMS for NH regulation 2003 update; adopted by Medicare D, HEDIS, NCQA 2012 evidence-based update Slide 6 Case Q1 82 y/o white man admitted with CAP, now ready to go home after completion of CAP rx. PMHx: diabetes, HTN, painful diabetic neuropathy Home meds : glyburide, lovastatin, clonidine, ASA, amitriptyline, pantoprazole Q1 How many of these meds are on the Beers list? Q2 What will you send the patient home on? Slide 7 Case Q2 77 y/o woman with dementia has recurrent UTIs and nausea. Urology suggests long-term suppressive therapy. Recent organisms have been sensitive to nitrofurantoin and Bactrim. Q1 What is best choice for urinary suppression? Q2 What drug is best choice for nausea? Slide 8 Criticisms of previous Beers list iterations Not evidence-based Many drugs on list were infrequently used Unstructured Uncertain relevance to clinical practice Many studies settings show that 20 30% of patients on Beers list meds Inconsistent assoc with ADE in epidemiologic studies Slide 9 NEISS-CADES Setting: 53 US hospitals Patients: 5077 pts > 64 years adm to hospital for ADE Findings: Half of hospitalizations were for pts >79 yrs old Two-thirds due to warfarin (33.3%), insulins (13.9%), oral antiplatelet agents (13.3%), and oral hypoglycemic agents (10.7%). Beers medications were implicated in 6.6% of hospitalizations for ADE, half of these digoxin Source: NEJM 2011;365:2002 Slide 10 2012 Beers Update Evidence-based approach by American Geriatric Society Incorporate exceptions Divide into three categories (Drugs to avoid, Drug-disease/syndrome interactions, Drugs to use with caution) Publish grade of evidence and strength of recommendation Slide 11 Evidence grade and strength of recommendations Grade of evidence High (>1 RCT or multiple consistent high quality observational studies) Moderate (1 RCT, or multiple consistent lower quality observational studies) Low (important study design flaws, inconsistent findings among studies) Strength of recommendations Strong (risk/burden clearly > benefit) Weak (benefits finely balanced with risk/burden) Insufficient (insufficient evidence to determine) Slide 12 Anticholinergics Source: JAGS 2012;60:616 Slide 13 Antibiotics Source: JAGS 2012;60:616 Slide 14 Cardiovascular drugs Source: JAGS 2012;60:616 Slide 15 Cardiovasc drugs (contd) Source: JAGS 2012;60:616 Slide 16 Psych drugs Source: JAGS 2012;60:616 Slide 17 Psych drugs (contd) Source: JAGS 2012;60:616 Slide 18 Endocrine drugs Source: JAGS 2012;60:616 Slide 19 Pain Source: JAGS 2012;60:616 Slide 20 Drug disease/synd interactions Source: JAGS 2012;60:616 Slide 21 Slide 22 Slide 23 Slide 24 Drugs to use with caution Source: JAGS 2012;60:616 Slide 25 Beers criteria and outpt studies Chang et al (Pharmacotherpy 2005;25:831) Setting: Taiwan Patients: 550 older pts seen in outpt clinic Findings: ADE OR = 15 Budnitz et al (Ann Intern Med 2007;147:755) Setting: Brazil Patients: 186 older outpts Findings: ADE OR = 2.3 Slide 26 Beers criteria and hosp studies Onder et al (Eur J Clin Pharmacol 2005;61:453) Setting: Italy Patients: 5,152 older pts adm to hosp Findings: No assoc Beers list and ADE, LOS or mortality LaRoche et al (Brit J Clin Pharm 2007;63:177) Setting: France Patients: 2,018 pts > 70 adm to hosp Findings: more ADR in pts on Beers list meds, but no diff in ADR attributable to Beers meds Slide 27 Beers and hospital studies Franceschi M, et al (Drug Safety 2008;31:545) Setting: Italy Patients: 1,756 older pts adm to hospital Findings: 4.4% of hospitalizations related to ADE that was definitely or possibly avoidable 1/5 of these ( BEERS vs STOPP (Hamilton. Arch Intern Med 2011; 171:1013) STOPP = Screening Tool of Older Persons potentially inappropriate Prescriptions Setting: Ireland Patients: 600 pts > 64 years adm to hosp Findings: ADE 26% 2/3 ADE causal or contributory to adm OR ADE 1.84 (95% CI = 1.51 2.26) with STOPP, 1.27 (95% CI = 0.94 1.72) with Beers Slide 29 Source: Arch Intern Med 2011;171:1013 Slide 30 Slide 31 Slide 32 Slide 33 Source:http://www.bgs.org.uk/powerpoint/aut10/Mahony_inappropriate_prescribing.pdf Slide 34 Slide 35 Slide 36 http://www.americangeriatrics.org/files/documents/annual_meeting/2012/handouts/friday/Joseph_Hanlon.pdf Slide 37 Case Q1 82 y/o white man admitted with CAP, now ready to go home after completion of CAP rx. PMHx: diabetes, HTN, painful diabetic neuropathy Home meds : glyburide, lovastatin, clonidine, ASA, amitriptyline, pantoprazole Q1 How many of these meds are on the Beers list? Q2 What will you send the patient home on? Slide 38 Case Q2 77 y/o woman with dementia has recurrent UTIs and nausea. Urology suggests long-term suppressive therapy. Recent organisms have been sensitive to nitrofurantoin and Bactrim. Q1 What is best choice for urinary suppression? Q2 What drug is best choice for nausea? Slide 39 Beers and Relevance to Hospital Medicine Education/resources (google AGS) Avoid starting Beers/STOPP meds in hospital Phenergan, benzos If Beers/STOPP meds started in hospital, consider stopping before go home Antipsychotics, opiates, zolpidem, ?loop diuretics for edema not due to CHF or cirrhosis For patients on Beers/STOPP meds on admission, consider communicating with PCP Redo admission order set; clinical decision support